Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO)
Italy · Delayed Price · Currency is EUR 1.095
0.00 (0.00%)
Last updated: Jun 9, 2026, 4:55 PM CET
BIT:ERFO Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 9.49 | 5.83 | 5.74 | 4.62 | 4.84 |
Other Revenue | 0.24 | 0.2 | 0.19 | 0.1 | 0.17 |
| 9.73 | 6.03 | 5.93 | 4.72 | 5.01 | |
Revenue Growth (YoY) | 61.32% | 1.69% | 25.70% | -5.74% | 24.09% |
Cost of Revenue | 6.04 | 3.49 | 3.33 | 2.27 | 2.24 |
Gross Profit | 3.7 | 2.54 | 2.6 | 2.45 | 2.77 |
Selling, General & Admin | 1.82 | 1.49 | 1.24 | 1.04 | 0.81 |
Amortization of Goodwill & Intangibles | 0.66 | 0.38 | 0.37 | 0.3 | 0.16 |
Other Operating Expenses | -0.15 | -0.17 | -0.22 | -0.21 | -0.08 |
Operating Expenses | 2.63 | 2.01 | 1.76 | 1.46 | 1.19 |
Operating Income | 1.07 | 0.52 | 0.84 | 0.99 | 1.58 |
Interest Expense | -0.06 | -0.03 | -0.03 | -0.04 | -0.02 |
Currency Exchange Gain (Loss) | -0 | -0 | 0 | - | - |
Other Non Operating Income (Expenses) | 0.04 | 0.03 | 0.01 | 0 | 0 |
EBT Excluding Unusual Items | 1.04 | 0.53 | 0.82 | 0.95 | 1.57 |
Gain (Loss) on Sale of Investments | - | - | - | - | -0.01 |
Pretax Income | 1.04 | 0.53 | 0.82 | 0.95 | 1.56 |
Income Tax Expense | 0.31 | 0.17 | 0.22 | 0.23 | 0.39 |
Net Income | 0.74 | 0.35 | 0.59 | 0.72 | 1.17 |
Net Income to Common | 0.74 | 0.35 | 0.59 | 0.72 | 1.17 |
Net Income Growth | 108.88% | -40.23% | -17.56% | -38.59% | 2.28% |
Shares Outstanding (Basic) | 9 | 9 | 9 | 9 | 2 |
Shares Outstanding (Diluted) | 9 | 9 | 9 | 9 | 2 |
Shares Change (YoY) | -0.68% | -0.26% | -4.44% | 500.00% | - |
EPS (Basic) | 0.09 | 0.04 | 0.07 | 0.08 | 0.78 |
EPS (Diluted) | 0.09 | 0.04 | 0.07 | 0.08 | 0.78 |
EPS Growth | 110.31% | -40.08% | -13.73% | -89.76% | - |
Free Cash Flow | 0.85 | 1.17 | 0.98 | 0.3 | 2.1 |
Free Cash Flow Per Share | 0.10 | 0.14 | 0.11 | 0.03 | 1.40 |
Dividend Per Share | - | - | 0.060 | - | - |
Gross Margin | 37.97% | 42.07% | 43.84% | 51.91% | 55.26% |
Operating Margin | 10.96% | 8.68% | 14.11% | 20.91% | 31.56% |
Profit Margin | 7.57% | 5.85% | 9.95% | 15.17% | 23.29% |
Free Cash Flow Margin | 8.74% | 19.46% | 16.58% | 6.39% | 41.87% |
EBITDA | 1.83 | 1.21 | 1.56 | 1.61 | 2.02 |
EBITDA Margin | 18.82% | 20.09% | 26.23% | 34.07% | 40.40% |
D&A For EBITDA | 0.77 | 0.69 | 0.72 | 0.62 | 0.44 |
EBIT | 1.07 | 0.52 | 0.84 | 0.99 | 1.58 |
EBIT Margin | 10.96% | 8.68% | 14.11% | 20.91% | 31.56% |
Effective Tax Rate | 29.30% | 32.96% | 27.58% | 24.50% | 25.06% |
Revenue as Reported | 10.03 | 6.34 | 6.26 | 5.03 | 5.13 |